利用外部辐射精确激活癌症治疗中的金属基剂
Yuting Wang1, Liling Meng1, Fang Zhao2,3
1Key Laboratory of Fermentation Engineering (Ministry of Education), National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Hubei Key Laboratory of Industrial Microbiology, School of Life and Health Sciences, Hubei University of Technology, Wuhan, 430068, China.
通过外部辐射激活的金属制剂为传统化疗提供了一个有希望的替代方案,克服耐药性并减少副作用,以加强癌症治疗.
科学领域:
- 在瘤学瘤学.
- 材料科学 材料科学 材料科学
- 纳米技术纳米技术
背景情况:
- 基化疗药物如思丁对于癌症治疗至关重要,但面临着包括耐药性,毒性和非特异性分布在内的局限性.
- 新兴的金属基药物提供了超越传统化疗的替代抗癌机制.
- 响应外部刺激的金属基药物为克服化疗的局限性提供了一个新的策略.
研究的目的:
- 审查通过外部辐射激活的金属基剂介导的癌症疗法.
- 探索增强抗癌效率和最小化副作用的策略.
- 讨论近红外 (NIR) 光,超声波 (美国) 和X射线激活金属基剂的潜力.
主要方法:
- 关于金属基抗癌剂的当前文献的综述.
- 专注于通过近红外 (NIR) 光,超声波 (US) 和X射线激活的疗法.
- 对精确的时空控制代理激活的策略的分析.
主要成果:
- 通过外部辐射激活的金属制剂可以达到向的抗癌效果.
- 与传统化疗相比,这些刺激反应策略显示出降低副作用和非交叉药物耐药性的潜力.
- 外部照射允许精确的时空控制,提高治疗效率.
结论:
- 由NIR光,US光或X射线激活的金属基剂代表了癌症治疗的重大进展.
- 这些方法为克服传统基化疗的局限性提供了有希望的解决方案.
- 预计这些新型金属制剂的进一步开发将促进癌症治疗策略的发展.
更多相关视频
09:01Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
06:20Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
相关概念视频
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
